国际皮肤性病学杂志    2002 28 (4): 208-211   ISSN: 2096-5540  CN: 32-1880/R   系统性红斑狼疮生物制剂治疗的研究进展 郝进, 郝飞 第三军医大学西南医院皮肤科 重庆 400038 收稿日期 2001-12-18  修回日期 null  网络版发布日期 null 参考文献  [1] Ruiz-Irastorza G,Khamashta MA,Castellino G,et al.Systemic lupus erythematosus.Lancet,2001,357(9261):1027-1032. [2] Mohan C,Shi Y,Laman JD,et al.Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis.J Immunol,1995,154(3):1470-1480. [3] Finck BK,Linsley PS,Wofsy D.Treatment of murine lupus with CTLA4Ig.Science,1994,265(5176):1225-1227. [4] Sfikakis PP,Via CS.Expression of CD28,CTLA4,CD80,and CD86molecules in patients with autoimmune rheumatic diseases:implications for immunotherapy.Clin Immunol Immunopathol,1997,83(3):195-198. [5] Liblau R,Tisch R,Bercovici N,et al.Systemic antigen in the treatment of T-cell-mediated autoimmune diseases.Immunol Today,1997,18(12):599-604. [6] Zimmerman R,Radhakrishnan J,Valeri A,et al.Advances in the treatment of lupus nephritis.Annu Rev Med,2001,52:63-78. [7] Strand V,Lee M.Intravenous immunoglobulin in the treatment of autoimmune disease.In Strand V,Scott DL,Simon LS:Novel therapeutic agents for the treatment of autoimmune disease.New York:Dekker,1997.235-256. [8] Weisman MH,Bluestein HG,Bemer CM,et al.Reduction in circulating dsDNA antibody titer after administration of LJP 394.J Rheumatol,1997,24(2):314-318. [9] Tumlin JA.Lupus nephritis:novel immunosuppressive modalities and future directions.Semin Nephrol,1999,19(1):67-76. [10] Pan CQ,Dodge TH,Baker DL,et al.Improved potency of hyperactive and actin-resistant human DNase I variants for treatment of cystic fibrosis and systemic lupus erythematosus.J Biol Chem,1998,273(29):18374-18381. [11] Balow JE,Boumpas DT,Austin HA 3rd.New prospects for treatment of lupus nephritis.Semin Nephrol,2000,20(1):32-39. [12] Evans CH,Whalen JD,Evans CH,et al.Gene therapy in autoimmune diseases.Ann Rheum Dis,1998,57(3):125-127. [13] Hong NM,Masuko-Hongo K,Sasakawa H,et al.Amelioration of lymphoid hyperplasia and hypergammaglobulinemia in lupus-prone mice(gld) by Fas-ligand gene transfer.J Autoimmun,1998,11(4):301-307. [14] Chuzhin Y,Reddy B,Budhai L,et al.Prolonged survival in murine SLE by adenoviral mediated CTLA4Ig gene transfer.Arthritis Rheum,1998,41(Suppl):S140-146. [15] Brodsky RA,Petri M,Jones RJ.Hematopoietic stem cell transplantation for systemic lupus erythematosus.Rheum Dis Clin North Am,2000,26(2):377-387. [16] Traynor AE,Schroeder J,Rosa RM,et al.Treatment of severe systemic lupus erythematosus with high-dose chemotherapy and haemopoietic stemcell transplantation:a phase I study.Lancet,2000,356(9231):701-707. [17] Tyndall A.Immunoablation and haemopoietic stem cell transplantation for severe autoimmune disease with special reference to systemic lupus erythematosus.Lupus,2001,10(3):214-215. 通讯作者: